Search results for "Sclerosis"

showing 10 items of 1583 documents

Red Cell Membrane Protein Lateral Mobility in Vascular Atherosclerotic Disease: Preliminary Report

1993

Erythrocyte AggregationMalePathologymedicine.medical_specialtyArteriosclerosisBiologyBiochemistryMembrane PotentialsPreliminary reportmedicineHumansAgedVascular diseaseErythrocyte MembraneAtherosclerotic diseaseCell BiologyMiddle AgedBlood Viscositymedicine.diseasePathophysiologyRed cell membraneRed blood cellmedicine.anatomical_structureMembrane proteinImmunologyFemaleCardiology and Cardiovascular MedicineMicrovascular Research
researchProduct

Cell-mediated lipoprotein transport: A novel anti-atherogenic concept

2010

Lipoprotein transport is thought to occur in the plasma compartment of the blood, where lipoproteins are modulated by various enzymatic reactions. Subsequently, lipoproteins can migrate through the endothelial barrier to the subendothelial space or are taken up by the liver. The interaction between pro-atherogenic (apoB-containing) lipoproteins and blood cells (especially monocytes and macrophages) in the subendothelial space is well known. This lipoprotein-inflammatory cell interplay is central in the development of the atherosclerotic plaque. In this review, a novel interaction is described between lipoproteins and both leukocytes and erythrocytes in the blood compartment. This lipoprotei…

ErythrocytesApolipoprotein BLipoproteinsComplement receptor 1Blood lipidsLeukocytesInternal MedicinemedicineAnimalsHumansEndothelial dysfunctionComplement ActivationApolipoproteins BbiologyBiological TransportGeneral MedicineLipoprotein(a)Atherosclerosismedicine.diseaseComplement systemCell biologyLiverBiochemistryLipoprotein transportbiology.proteinlipids (amino acids peptides and proteins)Inflammation Mediatorsbiology.geneCardiology and Cardiovascular MedicineLipoproteinAtherosclerosis Supplements
researchProduct

Estándares SEA 2019 para el control global del riesgo cardiovascular

2019

One of the main goals of the Spanish Society of Arteriosclerosis is to contribute to a wider and greater knowledge of vascular disease, its prevention and treatment. Cardiovascular diseases are the leading cause of death in our country and also lead to a high degree of disability and health expenditure. Arteriosclerosis is a multifactorial disease, this is why its prevention requires a global approach that takes into account the different risk factors with which it is associated. Thus, this document summarizes the current level of knowledge and integrates recommendations and procedures to be followed for patients with established cardiovascular disease or high vascular risk. Specifically, t…

Estimationmedicine.medical_specialtyVascular diseasebusiness.industryCardiovascular risk factorsNiceArteriosclerosisDisease030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicinemedicinePharmacology (medical)030212 general & internal medicineCardiology and Cardiovascular MedicineIntensive care medicinebusinesscomputerRisk managementCause of deathcomputer.programming_languageClínica e Investigación en Arteriosclerosis
researchProduct

Correlation between HHV-6 reactivation and multiple sclerosis disease activity.

2002

This study examined the association between HHV-6 infection and multiple sclerosis (MS) and the relationship between HHV-6 reactivation and disease activity. The frequency of HHV-6 genomic sequences in peripheral blood mononuclear cells (PBMCs), the incidence of plasma viremia (nPCR), the transcription of viral mRNA in PBMCs (RT-PCR), the presence of antiviral IgM and IgG class antibodies in the plasma (IFA) of 16 relapsing/remitting and secondary progressive MS patients were studied in comparison with clinical manifestations of the disease, magnetic resonance imaging (MRI) of brain, and serum interleukin (IL)-12 concentrations (ELISA). The prevalence of HHV-6 infection was significantly hi…

ExacerbationvirusesHerpesvirus 6 HumanViremiaEnzyme-Linked Immunosorbent Assaymedicine.disease_causePeripheral blood mononuclear cellHerpesviridaeCentral nervous system diseaseMultiple Sclerosis Relapsing-RemittingVirologymedicineHumansCells Culturedbiologybusiness.industryReverse Transcriptase Polymerase Chain ReactionMultiple sclerosisvirus diseasesInterleukinHerpesviridae Infectionsmedicine.diseaseVirologyInfectious DiseasesImmunoglobulin MImmunoglobulin GImmunologybiology.proteinLeukocytes MononuclearVirus ActivationAntibodybusinessJournal of medical virology
researchProduct

Acceptance of Mobile Health Apps for Disease Management Among People With Multiple Sclerosis: Web-Based Survey Study

2018

Background: Mobile health (mHealth) apps might have the potential to promote self-management of people with multiple sclerosis (MS) in everyday life. However, the uptake of MS apps remains poor, and little is known about the facilitators and barriers for their efficient utilization, such as technology acceptance. Objective: The aim of this study was to examine the acceptance of mHealth apps for disease management in the sense of behavioral intentions to use and explore determinants of utilization among people with MS based on the Unified Theory of Acceptance and Use of Technology (UTAUT). Methods: Participants for this Web-based cross-sectional study were recruited throughout Germany with t…

Expectancy theoryGerontologyOriginal Paper020205 medical informaticsmHealth acceptability of health careMedicine (miscellaneous)Health InformaticsHealth literacy02 engineering and technologyUnified theory of acceptance and use of technologymultiple sclerosisComputer Science Applications03 medical and health sciencesSocial support0302 clinical medicineModerated mediationHelpfulness0202 electrical engineering electronic engineering information engineeringeHealtheHealthPsychologymHealthpatient preference030217 neurology & neurosurgeryJMIR Formative Research
researchProduct

Cannabinoids in the management of spasticity associated with multiple sclerosis.

2008

Anna Maria Malfitano, Maria Chiara Proto, Maurizio BifulcoDipartimento di Scienze Farmaceutiche, Università degli Studi di SalernoAbstract: The endocannabinoid system and cannabinoid-based treatments have been involved in a wide number of diseases. In particular, several studies suggest that cannabinoids and endocannabinoids may have a key role in the pathogenesis and therapy of multiple sclerosis (MS). In this study we highlight the main findings reported in literature about the relevance of cannabinoid drugs in the management and treatment of MS. An increasing body of evidence suggests that cannabinoids have beneficial effects on the symptoms of MS, including spasticity and pai…

Experimental allergicbusiness.industryMultiple sclerosisEncephalomyelitismedicine.medical_treatmentspasticityNeurosciences. Biological psychiatry. NeuropsychiatryReviewPharmacologymedicine.diseasemultiple sclerosisEndocannabinoid systemPsychiatry and Mental healthcannabinoidsmedicinelipids (amino acids peptides and proteins)Neurology. Diseases of the nervous systemCannabinoidSpasticitymedicine.symptomRC346-429businessBeneficial effectsBiological PsychiatryRC321-571Neuropsychiatric disease and treatment
researchProduct

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene

2012

Background. Fabry disease (FD) is an X-linked inherited disease based on the absence or reduction of lysosomal-galactosidase (Gla) activity. The enzymatic defect results in progressive impairment of cerebrovascular, renal and cardiac function. Normally, female heterozygote mutation carriers are less strongly affected than male hemizygotes aggravating disease diagnosis. Method. Close examination of the patients by renal biopsy, echo- and electrocardiography and MRI. Blood work and subsequent DNA analysis were carried out utilizing approved protocols for PCR and Sequencing. MLPA analysis was done to unveil deletions within the GLA gene locus. Quantitative detection of Glycolipids in patient p…

Fabry diseaseTransplantationPathologymedicine.medical_specialtybusiness.industryOriginal ContributionsGenetic disorderLocus (genetics)Heterozygote advantageOriginal Articleslyso-Gb3multiple sclerosismedicine.diseaseBioinformaticsrenal involvementFabry diseaseExonNephrologyMedicineBiomarker (medicine)Multiplex ligation-dependent probe amplificationbusinessX-linked recessive inheritanceClinical Kidney Journal
researchProduct

The Length of Leukocyte and Femoral Artery Telomeres in Patients with Peripheral Atherosclerosis.

2022

The length of telomeres (TLs) that protect chromosome ends may reflect the age of cells as well as the degree of genetic material damage caused by external factors. Since leukocyte telomere length is associated with cardiovascular diseases, the aim of this study was to evaluate whether leukocyte TL reflects femoral artery wall telomeres of patients with atherosclerosis and lower limb ischemia. Samples of femoral artery wall and blood were collected from 32 patients qualified to surgical revascularization. The analysis included blood and artery wall telomere length measurement and biochemical parameters. The study indicated that there was a moderate correlation between artery wall TL and leu…

Femoral ArteryGeneticsLeukocytesHumanstelomere length; atherosclerosis; cholesterol; inflammation markersTelomereAtherosclerosisGenetics (clinical)Genes
researchProduct

Fisioterapia cardiocirculatoria

2010

El Espacio Europeo de Educación Superior (EEES) propugna un cambio metodológico en los estudios universitarios, al que sin duda contribuye el uso de las tecnologías de la información y la comunicación (TIC). En este contexto la Universitat de València promueve la creación de grupos de innovación educativa al efecto de facilitar el tránsito al nuevo paradigma . El material que a continuación se presenta, “Fisioterapia cardiocirculatoria”, se inscribe en esta línea y su elaboración se debe a la ayuda concedida por el Vicerectorat de Convergència Europea i Qualitat (Universitat de València) en la convocatoria de ayudas a proyectos para la utilización y la exploración de las nuevas tecnologías …

Fisioterapia; enfermedades cardiovasculares; multimediaUNESCO::CIENCIAS MÉDICAS::Cirugía::Cirugía del corazónUNESCO::CIENCIAS MÉDICAS::Patología::Patología cardiovascularUNESCO::CIENCIAS MÉDICAS ::Cirugía ::FisioterapiaUNESCO::CIENCIAS MÉDICAS::Medicina interna::CardiologíaUNESCO::CIENCIAS MÉDICAS::Patología::Arteriosclerosis
researchProduct

Food of the Gods for the Treatment of Multiple Sclerosis Related Fatigue?

2019

In their JNNP paper, Coe et al report the preliminary results of a feasibility trial on flavonoid enriched cocoa for the treatment of multiple sclerosis (MS) related fatigue, showing promising results that encourage the conduction of a phase III clinical trial to confirm the results of possible clinical effects on MS related fatigue.1 As described in the paper,1 fatigue is the most common symptom reported by individuals affected by MS, affecting the majority of patients. It is often present even when neurological disability is low and in the early stages of the disease, but impacts significantly the quality of life in MS patients, diminishing independence in everyday activities. Fatigue sym…

Flavonoidsmedicine.medical_specialtyNeurological disabilitybusiness.industryEveryday activitiesMultiple sclerosisDiseasemedicine.diseasemultiple sclerosisClinical trial03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineQuality of lifeDouble-Blind MethodPhysical therapymedicineFeasibility StudiesHumansSurgeryNeurology (clinical)Fatigue symptomsbusiness030217 neurology & neurosurgeryFatigue
researchProduct